nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.136	0.212	CbGbCtD
Zileuton—PTGS1—Etoposide—uterine cancer	0.0998	0.156	CbGbCtD
Zileuton—CYP1A2—Progesterone—uterine cancer	0.0996	0.156	CbGbCtD
Zileuton—CYP2C9—Progesterone—uterine cancer	0.0898	0.14	CbGbCtD
Zileuton—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0788	0.123	CbGbCtD
Zileuton—CYP3A4—Progesterone—uterine cancer	0.0522	0.0816	CbGbCtD
Zileuton—CYP1A2—Etoposide—uterine cancer	0.0446	0.0697	CbGbCtD
Zileuton—CYP3A4—Etoposide—uterine cancer	0.0234	0.0365	CbGbCtD
Zileuton—CYP3A4—Doxorubicin—uterine cancer	0.0159	0.0249	CbGbCtD
Zileuton—LTB4R—uterine cervix—uterine cancer	0.00841	0.0777	CbGeAlD
Zileuton—EPHX2—myometrium—uterine cancer	0.00795	0.0734	CbGeAlD
Zileuton—LTB4R—mammalian vulva—uterine cancer	0.00736	0.068	CbGeAlD
Zileuton—PTGS1—oviduct—uterine cancer	0.00598	0.0552	CbGeAlD
Zileuton—LTB4R—female gonad—uterine cancer	0.00573	0.053	CbGeAlD
Zileuton—LTB4R—vagina—uterine cancer	0.0057	0.0526	CbGeAlD
Zileuton—EPHX2—mammalian vulva—uterine cancer	0.00541	0.05	CbGeAlD
Zileuton—Liver disorder—Progesterone—uterine cancer	0.00533	0.0288	CcSEcCtD
Zileuton—UGT1A9—renal system—uterine cancer	0.00529	0.0489	CbGeAlD
Zileuton—EPHX2—uterus—uterine cancer	0.00516	0.0476	CbGeAlD
Zileuton—Liver disorder—Medroxyprogesterone Acetate—uterine cancer	0.00483	0.0261	CcSEcCtD
Zileuton—EPHX2—female gonad—uterine cancer	0.00422	0.039	CbGeAlD
Zileuton—EPHX2—vagina—uterine cancer	0.00419	0.0387	CbGeAlD
Zileuton—PTGS1—artery—uterine cancer	0.00396	0.0366	CbGeAlD
Zileuton—LTB4R—lymph node—uterine cancer	0.00369	0.0341	CbGeAlD
Zileuton—Vaginal inflammation—Progesterone—uterine cancer	0.00364	0.0196	CcSEcCtD
Zileuton—ALOX5—smooth muscle tissue—uterine cancer	0.0036	0.0333	CbGeAlD
Zileuton—ALOX5—decidua—uterine cancer	0.00353	0.0326	CbGeAlD
Zileuton—Vaginal infection—Progesterone—uterine cancer	0.00343	0.0185	CcSEcCtD
Zileuton—Hepatotoxicity—Dactinomycin—uterine cancer	0.00333	0.018	CcSEcCtD
Zileuton—Vaginal inflammation—Medroxyprogesterone Acetate—uterine cancer	0.00329	0.0178	CcSEcCtD
Zileuton—Hypertonia—Progesterone—uterine cancer	0.00319	0.0172	CcSEcCtD
Zileuton—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.00311	0.0168	CcSEcCtD
Zileuton—Lymphadenopathy—Progesterone—uterine cancer	0.00309	0.0167	CcSEcCtD
Zileuton—Sleep disorder—Progesterone—uterine cancer	0.00305	0.0164	CcSEcCtD
Zileuton—ALOX5—female reproductive system—uterine cancer	0.00278	0.0257	CbGeAlD
Zileuton—EPHX2—lymph node—uterine cancer	0.00271	0.0251	CbGeAlD
Zileuton—ALOX5—female gonad—uterine cancer	0.00253	0.0233	CbGeAlD
Zileuton—Hepatotoxicity—Etoposide—uterine cancer	0.00241	0.013	CcSEcCtD
Zileuton—Upper respiratory tract infection—Progesterone—uterine cancer	0.00212	0.0114	CcSEcCtD
Zileuton—Pain—Carboplatin—uterine cancer	0.00211	0.0114	CcSEcCtD
Zileuton—Jaundice—Progesterone—uterine cancer	0.00198	0.0107	CcSEcCtD
Zileuton—Conjunctivitis—Progesterone—uterine cancer	0.00198	0.0107	CcSEcCtD
Zileuton—Urinary tract infection—Progesterone—uterine cancer	0.00198	0.0107	CcSEcCtD
Zileuton—Body temperature increased—Carboplatin—uterine cancer	0.00195	0.0105	CcSEcCtD
Zileuton—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.0104	CcSEcCtD
Zileuton—Sinusitis—Progesterone—uterine cancer	0.00191	0.0103	CcSEcCtD
Zileuton—Hepatitis—Progesterone—uterine cancer	0.00183	0.00985	CcSEcCtD
Zileuton—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00969	CcSEcCtD
Zileuton—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00966	CcSEcCtD
Zileuton—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00933	CcSEcCtD
Zileuton—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00892	CcSEcCtD
Zileuton—ALOX5—lymph node—uterine cancer	0.00162	0.015	CbGeAlD
Zileuton—CYP1A2—renal system—uterine cancer	0.00161	0.0148	CbGeAlD
Zileuton—Flatulence—Progesterone—uterine cancer	0.00157	0.00845	CcSEcCtD
Zileuton—Tension—Progesterone—uterine cancer	0.00156	0.00841	CcSEcCtD
Zileuton—Nervousness—Progesterone—uterine cancer	0.00154	0.00833	CcSEcCtD
Zileuton—PTGS1—epithelium—uterine cancer	0.0015	0.0139	CbGeAlD
Zileuton—PTGS1—uterine cervix—uterine cancer	0.00149	0.0137	CbGeAlD
Zileuton—Ill-defined disorder—Progesterone—uterine cancer	0.00147	0.00795	CcSEcCtD
Zileuton—PTGS1—smooth muscle tissue—uterine cancer	0.00145	0.0134	CbGeAlD
Zileuton—Malaise—Progesterone—uterine cancer	0.00143	0.00773	CcSEcCtD
Zileuton—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00766	CcSEcCtD
Zileuton—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00762	CcSEcCtD
Zileuton—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00755	CcSEcCtD
Zileuton—PTGS1—renal system—uterine cancer	0.00139	0.0129	CbGeAlD
Zileuton—Arthralgia—Progesterone—uterine cancer	0.00135	0.0073	CcSEcCtD
Zileuton—Chest pain—Progesterone—uterine cancer	0.00135	0.0073	CcSEcCtD
Zileuton—Myalgia—Progesterone—uterine cancer	0.00135	0.0073	CcSEcCtD
Zileuton—PTGS1—endometrium—uterine cancer	0.00135	0.0124	CbGeAlD
Zileuton—Discomfort—Progesterone—uterine cancer	0.00134	0.00721	CcSEcCtD
Zileuton—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00721	CcSEcCtD
Zileuton—PTGS1—mammalian vulva—uterine cancer	0.0013	0.012	CbGeAlD
Zileuton—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00701	CcSEcCtD
Zileuton—Hepatitis—Dactinomycin—uterine cancer	0.00129	0.00696	CcSEcCtD
Zileuton—PTGS1—uterus—uterine cancer	0.00124	0.0115	CbGeAlD
Zileuton—Liver injury—Epirubicin—uterine cancer	0.00124	0.00668	CcSEcCtD
Zileuton—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00661	CcSEcCtD
Zileuton—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00661	CcSEcCtD
Zileuton—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00661	CcSEcCtD
Zileuton—CYP2C9—female reproductive system—uterine cancer	0.00122	0.0113	CbGeAlD
Zileuton—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00653	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00118	0.00638	CcSEcCtD
Zileuton—Insomnia—Progesterone—uterine cancer	0.00117	0.00633	CcSEcCtD
Zileuton—CYP3A4—renal system—uterine cancer	0.00116	0.0107	CbGeAlD
Zileuton—Somnolence—Progesterone—uterine cancer	0.00115	0.00622	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.00115	0.00618	CcSEcCtD
Zileuton—Liver injury—Doxorubicin—uterine cancer	0.00115	0.00618	CcSEcCtD
Zileuton—Dyspepsia—Progesterone—uterine cancer	0.00114	0.00616	CcSEcCtD
Zileuton—Gastrointestinal disorder—Progesterone—uterine cancer	0.00112	0.00604	CcSEcCtD
Zileuton—PTGS1—female reproductive system—uterine cancer	0.00111	0.0103	CbGeAlD
Zileuton—Constipation—Progesterone—uterine cancer	0.00111	0.00598	CcSEcCtD
Zileuton—Pain—Progesterone—uterine cancer	0.00111	0.00598	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00578	CcSEcCtD
Zileuton—Feeling abnormal—Progesterone—uterine cancer	0.00107	0.00577	CcSEcCtD
Zileuton—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00573	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.00106	0.00572	CcSEcCtD
Zileuton—Neck pain—Epirubicin—uterine cancer	0.00106	0.00569	CcSEcCtD
Zileuton—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00564	CcSEcCtD
Zileuton—Vaginal inflammation—Epirubicin—uterine cancer	0.00104	0.00562	CcSEcCtD
Zileuton—Ill-defined disorder—Dactinomycin—uterine cancer	0.00104	0.00562	CcSEcCtD
Zileuton—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00558	CcSEcCtD
Zileuton—Urticaria—Progesterone—uterine cancer	0.00103	0.00556	CcSEcCtD
Zileuton—Body temperature increased—Progesterone—uterine cancer	0.00103	0.00553	CcSEcCtD
Zileuton—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00547	CcSEcCtD
Zileuton—PTGS1—female gonad—uterine cancer	0.00101	0.00937	CbGeAlD
Zileuton—Jaundice—Etoposide—uterine cancer	0.00101	0.00547	CcSEcCtD
Zileuton—Malaise—Dactinomycin—uterine cancer	0.00101	0.00546	CcSEcCtD
Zileuton—PTGS1—vagina—uterine cancer	0.00101	0.00932	CbGeAlD
Zileuton—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00542	CcSEcCtD
Zileuton—Vaginal infection—Epirubicin—uterine cancer	0.000984	0.00531	CcSEcCtD
Zileuton—Neck pain—Doxorubicin—uterine cancer	0.000976	0.00527	CcSEcCtD
Zileuton—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000969	0.00522	CcSEcCtD
Zileuton—Vaginal inflammation—Doxorubicin—uterine cancer	0.000965	0.0052	CcSEcCtD
Zileuton—Myalgia—Dactinomycin—uterine cancer	0.000956	0.00516	CcSEcCtD
Zileuton—Hypersensitivity—Progesterone—uterine cancer	0.000956	0.00516	CcSEcCtD
Zileuton—Discomfort—Dactinomycin—uterine cancer	0.000945	0.0051	CcSEcCtD
Zileuton—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000934	0.00504	CcSEcCtD
Zileuton—CYP3A4—female reproductive system—uterine cancer	0.000931	0.0086	CbGeAlD
Zileuton—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000929	0.00501	CcSEcCtD
Zileuton—Pruritus—Progesterone—uterine cancer	0.000918	0.00495	CcSEcCtD
Zileuton—Hypertonia—Epirubicin—uterine cancer	0.000914	0.00493	CcSEcCtD
Zileuton—Vaginal infection—Doxorubicin—uterine cancer	0.000911	0.00491	CcSEcCtD
Zileuton—Diarrhoea—Progesterone—uterine cancer	0.000888	0.00479	CcSEcCtD
Zileuton—Lymphadenopathy—Epirubicin—uterine cancer	0.000887	0.00478	CcSEcCtD
Zileuton—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000866	0.00467	CcSEcCtD
Zileuton—Dizziness—Progesterone—uterine cancer	0.000858	0.00463	CcSEcCtD
Zileuton—Hypertonia—Doxorubicin—uterine cancer	0.000846	0.00456	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000835	0.00451	CcSEcCtD
Zileuton—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00449	CcSEcCtD
Zileuton—Vomiting—Progesterone—uterine cancer	0.000825	0.00445	CcSEcCtD
Zileuton—Lymphadenopathy—Doxorubicin—uterine cancer	0.000821	0.00443	CcSEcCtD
Zileuton—Rash—Progesterone—uterine cancer	0.000818	0.00441	CcSEcCtD
Zileuton—Dermatitis—Progesterone—uterine cancer	0.000817	0.00441	CcSEcCtD
Zileuton—Headache—Progesterone—uterine cancer	0.000813	0.00438	CcSEcCtD
Zileuton—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000804	0.00434	CcSEcCtD
Zileuton—Pain—Dactinomycin—uterine cancer	0.000784	0.00423	CcSEcCtD
Zileuton—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000777	0.00419	CcSEcCtD
Zileuton—Nausea—Progesterone—uterine cancer	0.000771	0.00416	CcSEcCtD
Zileuton—Feeling abnormal—Dactinomycin—uterine cancer	0.000756	0.00408	CcSEcCtD
Zileuton—Ill-defined disorder—Etoposide—uterine cancer	0.000754	0.00407	CcSEcCtD
Zileuton—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000747	0.00403	CcSEcCtD
Zileuton—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000741	0.004	CcSEcCtD
Zileuton—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00074	0.00399	CcSEcCtD
Zileuton—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000736	0.00397	CcSEcCtD
Zileuton—Malaise—Etoposide—uterine cancer	0.000733	0.00396	CcSEcCtD
Zileuton—Body temperature increased—Dactinomycin—uterine cancer	0.000725	0.00391	CcSEcCtD
Zileuton—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.00377	CcSEcCtD
Zileuton—Chest pain—Etoposide—uterine cancer	0.000692	0.00373	CcSEcCtD
Zileuton—Abdominal pain upper—Epirubicin—uterine cancer	0.000691	0.00373	CcSEcCtD
Zileuton—Discomfort—Etoposide—uterine cancer	0.000684	0.00369	CcSEcCtD
Zileuton—Hypersensitivity—Dactinomycin—uterine cancer	0.000676	0.00364	CcSEcCtD
Zileuton—PTGS1—lymph node—uterine cancer	0.000652	0.00603	CbGeAlD
Zileuton—Abdominal pain upper—Doxorubicin—uterine cancer	0.00064	0.00345	CcSEcCtD
Zileuton—Diarrhoea—Dactinomycin—uterine cancer	0.000627	0.00338	CcSEcCtD
Zileuton—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000608	0.00328	CcSEcCtD
Zileuton—Somnolence—Etoposide—uterine cancer	0.00059	0.00318	CcSEcCtD
Zileuton—Vomiting—Dactinomycin—uterine cancer	0.000583	0.00314	CcSEcCtD
Zileuton—Rash—Dactinomycin—uterine cancer	0.000578	0.00312	CcSEcCtD
Zileuton—Gastrointestinal disorder—Etoposide—uterine cancer	0.000573	0.00309	CcSEcCtD
Zileuton—Jaundice—Epirubicin—uterine cancer	0.000568	0.00307	CcSEcCtD
Zileuton—Constipation—Etoposide—uterine cancer	0.000567	0.00306	CcSEcCtD
Zileuton—Pain—Etoposide—uterine cancer	0.000567	0.00306	CcSEcCtD
Zileuton—Urinary tract infection—Epirubicin—uterine cancer	0.000567	0.00306	CcSEcCtD
Zileuton—Conjunctivitis—Epirubicin—uterine cancer	0.000567	0.00306	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000563	0.00303	CcSEcCtD
Zileuton—Sinusitis—Epirubicin—uterine cancer	0.000547	0.00295	CcSEcCtD
Zileuton—Feeling abnormal—Etoposide—uterine cancer	0.000547	0.00295	CcSEcCtD
Zileuton—Nausea—Dactinomycin—uterine cancer	0.000545	0.00294	CcSEcCtD
Zileuton—Urticaria—Etoposide—uterine cancer	0.000527	0.00284	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—uterine cancer	0.000526	0.00284	CcSEcCtD
Zileuton—Body temperature increased—Etoposide—uterine cancer	0.000525	0.00283	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—uterine cancer	0.000525	0.00283	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—uterine cancer	0.000525	0.00283	CcSEcCtD
Zileuton—Hepatitis—Epirubicin—uterine cancer	0.000524	0.00282	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—uterine cancer	0.000506	0.00273	CcSEcCtD
Zileuton—Hypersensitivity—Etoposide—uterine cancer	0.000489	0.00264	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—uterine cancer	0.000484	0.00261	CcSEcCtD
Zileuton—Pruritus—Etoposide—uterine cancer	0.000469	0.00253	CcSEcCtD
Zileuton—Diarrhoea—Etoposide—uterine cancer	0.000454	0.00245	CcSEcCtD
Zileuton—Flatulence—Epirubicin—uterine cancer	0.000449	0.00242	CcSEcCtD
Zileuton—Tension—Epirubicin—uterine cancer	0.000447	0.00241	CcSEcCtD
Zileuton—Nervousness—Epirubicin—uterine cancer	0.000443	0.00239	CcSEcCtD
Zileuton—Dizziness—Etoposide—uterine cancer	0.000439	0.00237	CcSEcCtD
Zileuton—Ill-defined disorder—Epirubicin—uterine cancer	0.000423	0.00228	CcSEcCtD
Zileuton—Vomiting—Etoposide—uterine cancer	0.000422	0.00228	CcSEcCtD
Zileuton—Rash—Etoposide—uterine cancer	0.000418	0.00226	CcSEcCtD
Zileuton—Dermatitis—Etoposide—uterine cancer	0.000418	0.00225	CcSEcCtD
Zileuton—Headache—Etoposide—uterine cancer	0.000416	0.00224	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—uterine cancer	0.000416	0.00224	CcSEcCtD
Zileuton—Tension—Doxorubicin—uterine cancer	0.000414	0.00223	CcSEcCtD
Zileuton—Malaise—Epirubicin—uterine cancer	0.000411	0.00222	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—uterine cancer	0.00041	0.00221	CcSEcCtD
Zileuton—Nausea—Etoposide—uterine cancer	0.000394	0.00213	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—uterine cancer	0.000391	0.00211	CcSEcCtD
Zileuton—Arthralgia—Epirubicin—uterine cancer	0.000388	0.00209	CcSEcCtD
Zileuton—Chest pain—Epirubicin—uterine cancer	0.000388	0.00209	CcSEcCtD
Zileuton—Myalgia—Epirubicin—uterine cancer	0.000388	0.00209	CcSEcCtD
Zileuton—Discomfort—Epirubicin—uterine cancer	0.000383	0.00207	CcSEcCtD
Zileuton—Malaise—Doxorubicin—uterine cancer	0.00038	0.00205	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—uterine cancer	0.000359	0.00194	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—uterine cancer	0.000359	0.00194	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—uterine cancer	0.000359	0.00194	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—uterine cancer	0.000355	0.00191	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000339	0.00183	CcSEcCtD
Zileuton—Insomnia—Epirubicin—uterine cancer	0.000336	0.00181	CcSEcCtD
Zileuton—Somnolence—Epirubicin—uterine cancer	0.000331	0.00178	CcSEcCtD
Zileuton—Dyspepsia—Epirubicin—uterine cancer	0.000327	0.00177	CcSEcCtD
Zileuton—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000321	0.00173	CcSEcCtD
Zileuton—Pain—Epirubicin—uterine cancer	0.000318	0.00172	CcSEcCtD
Zileuton—Constipation—Epirubicin—uterine cancer	0.000318	0.00172	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000314	0.00169	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—uterine cancer	0.000311	0.00168	CcSEcCtD
Zileuton—Feeling abnormal—Epirubicin—uterine cancer	0.000307	0.00165	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—uterine cancer	0.000306	0.00165	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—uterine cancer	0.000303	0.00163	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000297	0.0016	CcSEcCtD
Zileuton—Urticaria—Epirubicin—uterine cancer	0.000296	0.00159	CcSEcCtD
Zileuton—Pain—Doxorubicin—uterine cancer	0.000294	0.00159	CcSEcCtD
Zileuton—Constipation—Doxorubicin—uterine cancer	0.000294	0.00159	CcSEcCtD
Zileuton—Body temperature increased—Epirubicin—uterine cancer	0.000294	0.00159	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—uterine cancer	0.000284	0.00153	CcSEcCtD
Zileuton—Hypersensitivity—Epirubicin—uterine cancer	0.000274	0.00148	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—uterine cancer	0.000273	0.00147	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—uterine cancer	0.000272	0.00147	CcSEcCtD
Zileuton—Pruritus—Epirubicin—uterine cancer	0.000263	0.00142	CcSEcCtD
Zileuton—Diarrhoea—Epirubicin—uterine cancer	0.000255	0.00137	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—uterine cancer	0.000254	0.00137	CcSEcCtD
Zileuton—Dizziness—Epirubicin—uterine cancer	0.000246	0.00133	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—uterine cancer	0.000244	0.00131	CcSEcCtD
Zileuton—Vomiting—Epirubicin—uterine cancer	0.000237	0.00128	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—uterine cancer	0.000235	0.00127	CcSEcCtD
Zileuton—Rash—Epirubicin—uterine cancer	0.000235	0.00127	CcSEcCtD
Zileuton—Dermatitis—Epirubicin—uterine cancer	0.000234	0.00126	CcSEcCtD
Zileuton—Headache—Epirubicin—uterine cancer	0.000233	0.00126	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—uterine cancer	0.000228	0.00123	CcSEcCtD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000224	0.00336	CbGpPWpGaD
Zileuton—LTB4R—G alpha (q) signalling events—PIK3CA—uterine cancer	0.000223	0.00334	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000222	0.00332	CbGpPWpGaD
Zileuton—Nausea—Epirubicin—uterine cancer	0.000221	0.00119	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—uterine cancer	0.000219	0.00118	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	0.000217	0.00326	CbGpPWpGaD
Zileuton—Rash—Doxorubicin—uterine cancer	0.000217	0.00117	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—uterine cancer	0.000217	0.00117	CcSEcCtD
Zileuton—Headache—Doxorubicin—uterine cancer	0.000216	0.00116	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—INHBA—uterine cancer	0.000214	0.00321	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000214	0.0032	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000211	0.00317	CbGpPWpGaD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000211	0.00316	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000209	0.00313	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000209	0.00313	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—RRM2—uterine cancer	0.000206	0.00308	CbGpPWpGaD
Zileuton—Nausea—Doxorubicin—uterine cancer	0.000204	0.0011	CcSEcCtD
Zileuton—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000204	0.00305	CbGpPWpGaD
Zileuton—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000201	0.00301	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—DCN—uterine cancer	0.0002	0.00299	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	0.0002	0.00299	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000196	0.00294	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	0.000196	0.00294	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—CYP19A1—uterine cancer	0.000195	0.00292	CbGpPWpGaD
Zileuton—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000194	0.00291	CbGpPWpGaD
Zileuton—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000193	0.00289	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKR1C1—uterine cancer	0.000193	0.00289	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP11A1—uterine cancer	0.000188	0.00282	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	0.000185	0.00277	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKR1C3—uterine cancer	0.000178	0.00266	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CXCL8—uterine cancer	0.000177	0.00266	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—STAR—uterine cancer	0.000175	0.00262	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKR1B1—uterine cancer	0.000175	0.00262	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000173	0.00259	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000173	0.00259	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00017	0.00255	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00017	0.00255	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000169	0.00253	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000168	0.00252	CbGpPWpGaD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000165	0.00247	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000163	0.00244	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000157	0.00235	CbGpPWpGaD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000155	0.00232	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000153	0.0023	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000152	0.00227	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKR1C3—uterine cancer	0.000148	0.00223	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	0.000148	0.00222	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PGR—uterine cancer	0.000145	0.00217	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	0.000144	0.00216	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	0.000139	0.00209	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—STK11—uterine cancer	0.000138	0.00207	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP19A1—uterine cancer	0.000138	0.00207	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—YWHAE—uterine cancer	0.000138	0.00207	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	0.000137	0.00206	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—POLD1—uterine cancer	0.000137	0.00206	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—EP300—uterine cancer	0.000136	0.00205	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000134	0.002	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—FBXW7—uterine cancer	0.000132	0.00198	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.00013	0.00195	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	0.00013	0.00195	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NDUFB11—uterine cancer	0.000129	0.00193	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SRD5A2—uterine cancer	0.000129	0.00193	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKR1C1—uterine cancer	0.000128	0.00192	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000127	0.00191	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	0.000127	0.0019	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000125	0.00187	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000125	0.00187	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000124	0.00186	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000124	0.00186	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	0.000119	0.00179	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000118	0.00177	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	0.000117	0.00176	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STK11—uterine cancer	0.000116	0.00173	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL2—uterine cancer	0.000115	0.00173	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—RRM2—uterine cancer	0.000114	0.00171	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000114	0.00171	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000114	0.00171	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000111	0.00167	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—DCN—uterine cancer	0.000111	0.00166	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000111	0.00166	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SOCS3—uterine cancer	0.000108	0.00162	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000106	0.00159	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NDUFB11—uterine cancer	0.000105	0.00157	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SRD5A2—uterine cancer	0.000105	0.00157	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP11A1—uterine cancer	0.000105	0.00157	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—MTHFR—uterine cancer	0.000104	0.00156	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CDKN2B—uterine cancer	0.000104	0.00155	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	0.000103	0.00154	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000102	0.00153	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	0.000101	0.00152	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IGF1R—uterine cancer	0.000101	0.00151	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.0001	0.0015	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.0001	0.0015	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL8—uterine cancer	0.0001	0.0015	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKR1C3—uterine cancer	9.88e-05	0.00148	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	9.77e-05	0.00146	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.62e-05	0.00144	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	9.51e-05	0.00142	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SMAD3—uterine cancer	9.47e-05	0.00142	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	9.39e-05	0.00141	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKR1B1—uterine cancer	9.3e-05	0.00139	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—STAR—uterine cancer	9.3e-05	0.00139	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	9.2e-05	0.00138	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	9.19e-05	0.00138	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.19e-05	0.00138	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.16e-05	0.00137	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—uterine cancer	9.1e-05	0.00136	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	9.07e-05	0.00136	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—FGFR2—uterine cancer	9.03e-05	0.00135	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.95e-05	0.00134	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.95e-05	0.00134	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	8.76e-05	0.00131	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	8.64e-05	0.0013	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	8.56e-05	0.00128	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	8.08e-05	0.00121	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ESR1—uterine cancer	7.73e-05	0.00116	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—STK11—uterine cancer	7.69e-05	0.00115	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP19A1—uterine cancer	7.69e-05	0.00115	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.65e-05	0.00115	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.65e-05	0.00115	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—STAR—uterine cancer	7.58e-05	0.00114	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKR1B1—uterine cancer	7.58e-05	0.00114	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.49e-05	0.00112	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—NRAS—uterine cancer	7.3e-05	0.00109	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—POLD1—uterine cancer	7.3e-05	0.00109	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.22e-05	0.00108	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.89e-05	0.00103	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	6.87e-05	0.00103	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKR1C1—uterine cancer	6.82e-05	0.00102	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL2—uterine cancer	6.8e-05	0.00102	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	6.76e-05	0.00101	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	6.67e-05	0.001	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.57e-05	0.000984	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CA—uterine cancer	6.36e-05	0.000953	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—KRAS—uterine cancer	6.29e-05	0.000942	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—RRM2—uterine cancer	6.08e-05	0.000912	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—POLD1—uterine cancer	5.95e-05	0.000892	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—DCN—uterine cancer	5.91e-05	0.000885	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTEN—uterine cancer	5.78e-05	0.000867	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—MTHFR—uterine cancer	5.78e-05	0.000867	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CA—uterine cancer	5.77e-05	0.000866	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ERBB2—uterine cancer	5.67e-05	0.00085	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.61e-05	0.000841	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKR1C1—uterine cancer	5.56e-05	0.000834	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP11A1—uterine cancer	5.56e-05	0.000834	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—EP300—uterine cancer	5.52e-05	0.000827	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SRD5A2—uterine cancer	5.51e-05	0.000826	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NDUFB11—uterine cancer	5.51e-05	0.000826	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—uterine cancer	5.38e-05	0.000806	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.35e-05	0.000802	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—HRAS—uterine cancer	5.34e-05	0.000801	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKR1C3—uterine cancer	5.25e-05	0.000788	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CDKN1B—uterine cancer	5.25e-05	0.000787	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AKT1—uterine cancer	5.19e-05	0.000779	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.1e-05	0.000764	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.06e-05	0.000758	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CTNNB1—uterine cancer	4.96e-05	0.000744	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—RRM2—uterine cancer	4.96e-05	0.000743	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTEN—uterine cancer	4.84e-05	0.000725	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—DCN—uterine cancer	4.81e-05	0.000722	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AKT1—uterine cancer	4.72e-05	0.000707	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NDUFB11—uterine cancer	4.71e-05	0.000706	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SRD5A2—uterine cancer	4.71e-05	0.000706	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EP300—uterine cancer	4.61e-05	0.000691	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.57e-05	0.000686	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP11A1—uterine cancer	4.54e-05	0.00068	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—uterine cancer	4.37e-05	0.000655	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.32e-05	0.000648	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NRAS—uterine cancer	4.31e-05	0.000647	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKR1C3—uterine cancer	4.28e-05	0.000642	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP19A1—uterine cancer	4.09e-05	0.000614	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—STK11—uterine cancer	4.09e-05	0.000614	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—uterine cancer	4.08e-05	0.000612	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.98e-05	0.000597	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—STAR—uterine cancer	3.98e-05	0.000597	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.94e-05	0.00059	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.84e-05	0.000576	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KRAS—uterine cancer	3.71e-05	0.000557	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.66e-05	0.000549	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.63e-05	0.000545	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.63e-05	0.000545	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—uterine cancer	3.41e-05	0.000511	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—STAR—uterine cancer	3.41e-05	0.00051	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKR1B1—uterine cancer	3.41e-05	0.00051	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.37e-05	0.000505	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—STK11—uterine cancer	3.34e-05	0.0005	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP19A1—uterine cancer	3.34e-05	0.0005	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—uterine cancer	3.33e-05	0.0005	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—uterine cancer	3.3e-05	0.000495	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—uterine cancer	3.22e-05	0.000482	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HRAS—uterine cancer	3.16e-05	0.000473	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.13e-05	0.00047	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—POLD1—uterine cancer	3.13e-05	0.000469	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—MTHFR—uterine cancer	3.08e-05	0.000461	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—EP300—uterine cancer	3.07e-05	0.00046	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.99e-05	0.000448	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.92e-05	0.000438	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—uterine cancer	2.79e-05	0.000418	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.71e-05	0.000406	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—POLD1—uterine cancer	2.67e-05	0.000401	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.63e-05	0.000394	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—STAR—uterine cancer	2.63e-05	0.000394	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—RRM2—uterine cancer	2.61e-05	0.000391	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—DCN—uterine cancer	2.53e-05	0.000379	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—MTHFR—uterine cancer	2.51e-05	0.000376	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.5e-05	0.000375	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.38e-05	0.000357	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—uterine cancer	2.27e-05	0.00034	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.25e-05	0.000338	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—RRM2—uterine cancer	2.23e-05	0.000334	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.21e-05	0.000331	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—DCN—uterine cancer	2.16e-05	0.000324	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—POLD1—uterine cancer	2.06e-05	0.000309	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP11A1—uterine cancer	2.04e-05	0.000305	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.93e-05	0.000289	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.92e-05	0.000288	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—uterine cancer	1.85e-05	0.000278	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.75e-05	0.000263	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—STK11—uterine cancer	1.75e-05	0.000263	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—RRM2—uterine cancer	1.72e-05	0.000258	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—uterine cancer	1.71e-05	0.000256	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—DCN—uterine cancer	1.67e-05	0.00025	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.65e-05	0.000247	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—EP300—uterine cancer	1.63e-05	0.000245	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.57e-05	0.000236	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.57e-05	0.000235	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.5e-05	0.000225	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—STK11—uterine cancer	1.5e-05	0.000225	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.48e-05	0.000223	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.41e-05	0.000211	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—uterine cancer	1.39e-05	0.000209	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.34e-05	0.000201	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—EP300—uterine cancer	1.33e-05	0.000199	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTHFR—uterine cancer	1.32e-05	0.000198	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—uterine cancer	1.21e-05	0.000181	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.16e-05	0.000174	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.000173	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—STK11—uterine cancer	1.16e-05	0.000173	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTHFR—uterine cancer	1.13e-05	0.000169	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.93e-06	0.000149	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—uterine cancer	9.86e-06	0.000148	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—uterine cancer	9.84e-06	0.000148	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTHFR—uterine cancer	8.69e-06	0.00013	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—uterine cancer	8.04e-06	0.000121	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—uterine cancer	7.33e-06	0.00011	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—EP300—uterine cancer	6.99e-06	0.000105	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—uterine cancer	6.27e-06	9.39e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—EP300—uterine cancer	5.98e-06	8.96e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—uterine cancer	5.17e-06	7.75e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—uterine cancer	4.84e-06	7.25e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—EP300—uterine cancer	4.61e-06	6.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—uterine cancer	4.42e-06	6.63e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—uterine cancer	4.23e-06	6.33e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—uterine cancer	3.61e-06	5.41e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.41e-06	5.11e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—uterine cancer	2.79e-06	4.18e-05	CbGpPWpGaD
